• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

T 细胞清除流感病毒感染:是否存在附带损伤风险?

Clearance of influenza virus infections by T cells: risk of collateral damage?

机构信息

Viroscience Lab, Erasmus MC, Rotterdam, The Netherlands.

出版信息

Curr Opin Virol. 2013 Aug;3(4):430-7. doi: 10.1016/j.coviro.2013.05.002. Epub 2013 May 27.

DOI:10.1016/j.coviro.2013.05.002
PMID:23721864
Abstract

Influenza A viruses are a major cause of respiratory infections in humans. To protect against influenza, vaccines mainly aim at the induction of antibodies against the two surface proteins and do not protect against influenza A viruses from other subtypes. There is an increasing interest in heterosubtypic immunity that does protect against different subtypes. CD8 and CD4 T cells have a beneficial effect on the course of influenza A virus infection and can recognize conserved IAV epitopes. The T cell responses are tightly regulated to avoid collateral damage due to overreaction. Different studies have shown that an aberrant T cell response to an influenza virus infection could be harmful and could contribute to immunopathology. Here we discuss the recent findings on the balance between the beneficial and detrimental effects of T cell responses in influenza virus infections.

摘要

甲型流感病毒是人类呼吸道感染的主要原因。为了预防流感,疫苗主要针对诱导针对两种表面蛋白的抗体,而不能预防来自其他亚型的甲型流感病毒。人们对异源型免疫的兴趣越来越大,这种免疫确实可以预防不同的亚型。CD8 和 CD4 T 细胞对甲型流感病毒感染的病程有有益的影响,可以识别保守的 IAV 表位。T 细胞反应受到严格调控,以避免因过度反应而造成的附带损伤。不同的研究表明,甲型流感病毒感染时 T 细胞反应异常可能是有害的,并可能导致免疫病理学。在这里,我们讨论了关于 T 细胞反应在流感病毒感染中的有益和有害影响之间平衡的最新发现。

相似文献

1
Clearance of influenza virus infections by T cells: risk of collateral damage?T 细胞清除流感病毒感染:是否存在附带损伤风险?
Curr Opin Virol. 2013 Aug;3(4):430-7. doi: 10.1016/j.coviro.2013.05.002. Epub 2013 May 27.
2
[Research Progress of Study on Function of T Cell Immunity against Influenza Virus].[T细胞免疫抗流感病毒作用的研究进展]
Bing Du Xue Bao. 2015 Jul;31(4):440-9.
3
Virus-specific T cells as correlate of (cross-)protective immunity against influenza.病毒特异性T细胞作为流感(交叉)保护性免疫的相关指标。
Vaccine. 2015 Jan 15;33(4):500-6. doi: 10.1016/j.vaccine.2014.11.054. Epub 2014 Dec 9.
4
Cytotoxic T cell vaccination with PLGA microspheres interferes with influenza A virus replication in the lung and suppresses the infectious disease.载药 PLGA 微球的细胞毒性 T 细胞疫苗干预肺内流感病毒复制并抑制传染性疾病。
J Control Release. 2015 Oct 28;216:121-31. doi: 10.1016/j.jconrel.2015.08.019. Epub 2015 Aug 12.
5
T cell mediated immunity to influenza: mechanisms of viral control.T 细胞介导的流感免疫:病毒控制机制。
Trends Immunol. 2014 Aug;35(8):396-402. doi: 10.1016/j.it.2014.06.004. Epub 2014 Jul 16.
6
Heterosubtypic immunity against human influenza A viruses, including recently emerged avian H5 and H9 viruses, induced by FLU-ISCOM vaccine in mice requires both cytotoxic T-lymphocyte and macrophage function.由FLU-ISCOM疫苗在小鼠中诱导产生的针对人类甲型流感病毒(包括最近出现的禽流感H5和H9病毒)的异源亚型免疫需要细胞毒性T淋巴细胞和巨噬细胞功能。
Cell Immunol. 2001 Aug 1;211(2):143-53. doi: 10.1006/cimm.2001.1835.
7
Why Are CD8 T Cell Epitopes of Human Influenza A Virus Conserved?为什么人类流感 A 病毒的 CD8 T 细胞表位是保守的?
J Virol. 2019 Mar 5;93(6). doi: 10.1128/JVI.01534-18. Print 2019 Mar 15.
8
[Immunity against influenza virus infection].[针对流感病毒感染的免疫力]
Nihon Rinsho. 2010 Sep;68(9):1625-30.
9
Pediatric influenza vaccination: understanding the T-cell response.儿童流感疫苗接种:了解 T 细胞反应。
Expert Rev Vaccines. 2012 Aug;11(8):963-71. doi: 10.1586/erv.12.69.
10
Long-term surviving influenza infected cells evade CD8+ T cell mediated clearance.长期存活的流感感染细胞逃避 CD8+T 细胞介导的清除。
PLoS Pathog. 2019 Sep 26;15(9):e1008077. doi: 10.1371/journal.ppat.1008077. eCollection 2019 Sep.

引用本文的文献

1
Viral sepsis: diagnosis, clinical features, pathogenesis, and clinical considerations.病毒性脓毒症:诊断、临床特征、发病机制及临床考量
Mil Med Res. 2024 Dec 16;11(1):78. doi: 10.1186/s40779-024-00581-0.
2
Aerosol immunization with influenza matrix, nucleoprotein, or both prevents lung disease in pig.用流感病毒基质蛋白、核蛋白或两者进行气溶胶免疫可预防猪的肺部疾病。
NPJ Vaccines. 2024 Oct 13;9(1):188. doi: 10.1038/s41541-024-00989-8.
3
The therapeutic effect of Yinqiaosan decoction against influenza A virus infection by regulating T cell receptor signaling pathway.
银翘散汤剂通过调节T细胞受体信号通路对甲型流感病毒感染的治疗作用。
Heliyon. 2024 Aug 13;10(16):e36178. doi: 10.1016/j.heliyon.2024.e36178. eCollection 2024 Aug 30.
4
SARS-CoV-2 Vaccines: The Advantage of Mucosal Vaccine Delivery and Local Immunity.严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)疫苗:黏膜疫苗接种与局部免疫的优势
Vaccines (Basel). 2024 Jul 18;12(7):795. doi: 10.3390/vaccines12070795.
5
Mucosal T-cell responses to chronic viral infections: Implications for vaccine design.黏膜 T 细胞对慢性病毒感染的反应:对疫苗设计的启示。
Cell Mol Immunol. 2024 Sep;21(9):982-998. doi: 10.1038/s41423-024-01140-2. Epub 2024 Mar 8.
6
T cell-specific P2RX7 favors lung parenchymal CD4 T cell accumulation in response to severe lung infections.T 细胞特异性 P2RX7 有利于严重肺部感染时肺实质 CD4 T 细胞的积聚。
Cell Rep. 2023 Nov 28;42(11):113448. doi: 10.1016/j.celrep.2023.113448. Epub 2023 Nov 15.
7
Interferon-γ couples CD8 T cell avidity and differentiation during infection.干扰素-γ 在感染过程中连接 CD8 T 细胞的亲和力和分化。
Nat Commun. 2023 Oct 23;14(1):6727. doi: 10.1038/s41467-023-42455-4.
8
Impact of influenza vaccination on survival of patients with advanced cancer receiving immune checkpoint inhibitors (INVIDIa-2): final results of the multicentre, prospective, observational study.流感疫苗接种对接受免疫检查点抑制剂的晚期癌症患者生存的影响(INVIDIa-2):多中心、前瞻性、观察性研究的最终结果
EClinicalMedicine. 2023 Jun 29;61:102044. doi: 10.1016/j.eclinm.2023.102044. eCollection 2023 Jul.
9
Regulatory T Cells (Tregs) and COVID-19: Unveiling the Mechanisms, and Therapeutic Potentialities with a Special Focus on Long COVID.调节性T细胞(Tregs)与新冠病毒病(COVID-19):揭示其机制及治疗潜力,特别关注新冠后综合征
Vaccines (Basel). 2023 Mar 19;11(3):699. doi: 10.3390/vaccines11030699.
10
Updated Insights into the T Cell-Mediated Immune Response against SARS-CoV-2: A Step towards Efficient and Reliable Vaccines.对SARS-CoV-2的T细胞介导免疫反应的最新见解:迈向高效可靠疫苗的一步。
Vaccines (Basel). 2023 Jan 1;11(1):101. doi: 10.3390/vaccines11010101.